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INTRODUCTION
Endometrial carcinoma is the most common ma-
lignancy of the female genital tract, accounting for
almost one half of all gynecologic cancers in the
United States. In 2006, it is estimated that there
were 41,200 new cases and 7,350 cancer-related
deaths. Endometrial carcinoma is the fourth most
common cancer, ranking behind breast, lung, and
bowel cancers, and the eighth leading cause of
death from malignancy in women. Overall, about 2
% to 3 % of women develop endometrial cancer
during their lifetime.1
Endometrial cancer is a disease that occurs pri-
marily in postmenopausal women and the inci-
dence is increasing along with advancing age. The
role of estrogen in the development of most en-
dometrial cancers has clearly been established. Any
factor that increases exposure to unopposed estro-
gen increases the risk for endometrial cancer.2
Several studies have identified risk factors of en-
dometrial cancer among older women, such as
overweight status, estrogen replacement therapy,
null parity, infertility, diabetes mellitus, and hyper-
tension.3-10 Most of these risk factors are related
to prolonged, unopposed estrogen stimulation of
the endometrium. Nulliparous women have 2 to 3
times the risk of multiparous women. Infertility
and a history of irregular menses as a result of
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Abstrak
Tujuan: Mengetahui apakah diabetes mellitus dan/atau hipertensi
berhubungan dengan kanker endometrium dan meningkatkan sta-
dium dari kanker.
Metode: Penelitian retrospektif deskriptif analitik dengan metode po-
tong silang. Data diperoleh dari rekam medik pasien yang dirawat
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anovulatory cycles (prolonged exposure to estro-
gen without sufficient progesterone) increase the
risk. Natural menopause occurring after the age of
52 years old increases the risk for endometrial can-
cer as much as 2.4 times compared with women
who had menopause before 49 years of age, prob-
ably as a result of prolonged exposure of the uterus
to progesterone-deficient menstrual cycles.4,9,11-14
Diabetes is associated with hypertension which
in turn have been related to endometrial cancer
risk.15-17
We therefore investigated whether a diabetes
mellitus and hypertension associated with en-
dometrial cancer and increased the staging of the
cancer.
METHOD
This was analytic retrospective descriptive study
with cross sectional design. Data were taken from
medical record of patients admitted with diag-
nosed of endometrial cancer in Obstetrics and Gy-
necology Department of Dr. Hasan Sadikin Hospital
from 1st January 2007 - 31st December 2011 and
analyzed descriptively.
RESULT
There were 125 cases of endometrial cancer from
4872 gynecologic cancer that was admitted in Ob-
stetrics and Gynecology Department of Dr. Hasan
Sadikin Hospital from 1st January 2007 - 31st De-
cember 2011 with prevalence of 2.56 %.
Table 1. Distribution of endometrial cancer cases by age.
Age (y/o) Cases (n) Percentage (%)
< 40  10   8.0
40 - 50  36  28.8
> 50  79  63.2
Total 125 100  
Table 1 showed that the prevalence of en-
dometrial cancer increased by age, in which 92 %
of the patients were above 40 years old. The age
of those patients were distributed at 33 to 79 years
old.
Table 2. Distribution of endometrial cancer based on
underlying disease.
Underlying
disease
Cases
(n)
Percentage
(%)
Diabetes  15  12.0
Hypertension  35  28.0
Diabetes and hypertension  33  26.4
None  42  33.6
Total 125 100  
Table 2 showed that 66.4 % of the endometrial
cancer patients had either diabetes mellitus and/
or hypertension as their underlying disease.
Table 3. Correlation between underlying disease and
endometrial cancer stage.
Underlying
disease
Stage
Total
I II III IV
Diabetes  5  4  6  0  15
Hypertension  8  8 14  5  35
Diabetes and hypertension  6  7 14  6  33
None 13 13 12  4  42
Total 32 32 46 15 125
Table 3 showed that the underlying disease
either diabetes mellitus and/or hypertension can-
not be proven to increase the staging of en-
dometrial cancer.
DISCUSSION
Generally, the etiology of endometrial cancer is
multi-factorial. The pathogenesis may be explained
by the estrogen theory. Increased availability of es-
trogen to the estrogen sensitive endometrium in-
creases the risk of endometrial cancer. Thus their
separate and mutual effects on the plasma estrogen
concentration explain the contribution of different
risk factors. The main source of plasma estrogen
in premenopausal women is the ovarium. In post-
menopausal women, the primary source of estro-
gen is the extra glandular conversion of andros-
tenedione to estrone and estradiol. This aromati-
zation occurs in adipose tissue, which is particularly
rich in enzymes facilitating this process. In post-
menopausal women the concentration of plasma
estrogen is reduced by 70 % to 80 % of pre-
menopausal level.18
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In this study, the association between diabetes
mellitus and/or hypertension with endometrial
cancer was showed in 66.4 % patients. Some stud-
ies have found diabetes to be a risk factor for en-
dometrial cancer among premenopausal women,19
whereas other studies have not been able to con-
firm this association.20-22 The influence has been
explained by higher levels of estrone and lipids in
the plasma of women with diabetes.23
Hypertension in some studies have reported an
odds ratio as great as 2.1 among postmenopausal
women, possibly as a result of an association be-
tween hypertension and body weight.3 Other stud-
ies have not been able to demonstrate this associa-
tion.4
Women with diabetes mellitus and hypertension
are at increased risk for endometrial cancer. Co-
morbid factors, primarily obesity, account for much
of this risk,24,25 but some studies have found inde-
pendent effects, as well.4,15,26-33 The risk of devel-
oping endometrial cancer is higher in type 2 than
type 1 diabetics. Diets high is carbohydrates and
associated hyperinsulinemia, insulin resistance,
and elevated levels of insulin-like growth factors
may play a role in endometrial proliferation and
development of endometrial cancer; this is an area
of active investigation.27,34-37
In this study, we can see that diabetes mellitus
and hypertension seems to be not associated with
increasing staging of the endometrial cancer.
Other prospective study should be held using
another method to improve the quality of this
study.
CONCLUSION
Diabetes mellitus and/or hypertension were asso-
ciated with risk factors of endometrial cancer but
not proven to increase the staging of the cancer.
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